A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axisYuanyuan Yan, Minjie Wei, Miao He et al.|Cell Death and Differentiation|2022Cited by 100
Expression and clinicopathological significance of FSIP1 in breast cancerHao Zhang, Caigang Liu, Ming Sun et al.|Oncotarget|2015Cited by 24